Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Alzheimer's Disease Parkinson's Disease Article COVID-19 and Dementia: a conjunction of pandemics Anxiety Article Optimising clinical management in panic disorder Alzheimer's Disease Article Could targeting the brain’s clearance systems be beneficial in Alzheimer’s Disease?